J Korean Neurol Assoc.  2003 Apr;21(2):174-182.

Neuroprotective Effect of Genistein Against beta Amyloid-Induced Neurotoxicity

Affiliations
  • 1Department of Neurology, Ajou University, School of Medicine, 5 San Woncheon-dong, Paldal-gu, Suwon-si, 442-749, Korea. nmboy@unitel.co.kr
  • 2Brain Disease Research Center, Ajou University, School of Medicine, Korea.

Abstract

BACKGROUND
Estrogen is beneficial to patients with Alzheimer's disease but has a limited clinical use due to its proliferative and oncogenic effects on non-neuronal estrogen responsive cells. METHODS: In an attempt to find an estrogen substitute that retains the beneficial effects of estrogen with minimal side effects, we compared the neuroprotective and proliferative effects of genistein, a selective estrogen receptor betaagonist, with those of estrogen. RESULTS: Genistein and 17beta-estradiol showed comparable levels of protection against Abeta-induced death of cultured SH-SY5Y human neuroblastoma cells, which was blocked by an estrogen receptor antagonist, ICI 182, 780. On the other hand, 17beta-estradiol, but not geninstein, induced proliferation of uterine endometrial cells. CONCLUSIONS: Our results suggest genistein as a potential alternative to estrogen in the treatment of Alzheimer's disease.

Keyword

Estrogen; Genistein; Beta amyloid; Alzheimer's disease; Cell death; Estrogen receptor

MeSH Terms

Alzheimer Disease
Cell Death
Estrogens
Genistein*
Hand
Humans
Neuroblastoma
Neuroprotective Agents*
Estrogens
Genistein
Neuroprotective Agents
Full Text Links
  • JKNA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr